Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment

Yazd Medical University1 个研究点分布在 1 个国家目标入组 520 人开始时间: 2008年4月最近更新: 2012年3月2日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 520
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

This study evaluated the effect of anticoagulant treatment on the live-birth rate in women with a history of at least two continuous unexplained miscarriages or thrombophilia. It also compared two methods of treatment with aspirin and aspirin plus heparin.

研究设计

研究类型: Observational
观察模型: Case Control
时间视角: Retrospective

入排标准

年龄范围: 19 Years 至 35 Years（Adult）
性别: Female
接受健康志愿者: 是

入选标准

•unexplained recurrent miscarriage,
•women had previous venous or arterial thromboembolism or who were heterozygous or homozygous for mutations for FV Leiden G1691A, prothrombin gene G20210A (FII G20210A), and methyltetrahydrofolate reductase C677T (MTHFR C677T)

排除标准

•abnormal karyotypes of both partners,
•uterine and cervical anatomical disorders on pelvic ultrasonography or hysteroscopy,
•abnormal ovaries and abnormal endocrine tests.

研究者

发起方

Yazd Medical University

申办方类型

Other

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

3 期

The Effect of Low Dose Aspirin in Increasing the Chance of PregnancyInfertility

NCT01633528Royan Institute60

已完成

不适用

Assessment of the Efficacy of the First Aspirin Dose in Children Undergoing Surgery for Congenital Heart Disease (CHD) Who Require Post-operative Antiplatelet TherapyCongenital Heart Disease

NCT02064179University of Colorado, Denver75

Unknown

不适用

Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure WomenRecurrent Implantation Failure

NCT03365466Shanghai First Maternity and Infant Hospital200

已完成

不适用

Aspirin and heparin in recurrent pregnancy loss treatmentSpontaneous abortionrecurrent pregnancy loss.

IRCT2013102315123N1Research and Clinical Center for Infertility,Yazd, Iran252

进行中（未招募）

1 期

BENEFIT OF ANTI-COAGULATION THERAPY IN PATIENTS WITH SEPTIC SHOCK.HEPARIN Anticoagulation to improve outcomes in septic shock : the HALO International Phase II RCTMedDRA version: 20.0Level: PTClassification code 10040047Term: SepsisSystem Organ Class: 10021881 - Infections and infestations

EUCTR2018-003726-93-GRHELLENIC INSTITUTE FOR THE STUDY OF SEPSIS500